Luminous Medical raises $9m to market automated glucose monitor:
This article was originally published in Clinica
Executive Summary
Carlsbad, California-based Luminous Medical is taking its first product - an automated, continuous whole blood glucose monitor for critically ill patients - one step closer to market after securing $9m in a round of financing led by medtech venture capital firms, De Novo Ventures and Matterell Venture Partners. The proceeds will be used to complete the development of the first-generation monitor and to further explore its capabilities. The device incorporates an optical technology licensed from InLight Solutions, the Albuquerque, New Mexico-based sensor-based measurement systems developer from which Luminous was spun off.